L’Oréal is set to take over the coveted Gucci license in a few short years, but losing a key brand is just one of the US conglomerate’s woes.
L’Oréal is set to take over the coveted Gucci license in a few short years, but losing a key brand is just one of the US conglomerate’s woes.
The future of big-name brands like Neutrogena, Clean & Clear and Aveeno, which bring more than $4 billion a year in sales, is less clear under its new ownership by the tissue and feminine care giant Kimberly-Clark.
The future of big-name brands like Neutrogena, Clean & Clear and Aveeno, which bring more than $4 billion a year in sales, is less clear under its new ownership by the tissue and feminine care giant Kimberly-Clark.
The US giant handily beat expectations and its own guidance in its latest earnings, but softness in the US and its hair and makeup businesses show it can’t take its foot off the gas yet.
The US giant handily beat expectations and its own guidance in its latest earnings, but softness in the US and its hair and makeup businesses show it can’t take its foot off the gas yet.
The news that LVMH might sell off its stake in Rihanna’s Fenty raises questions about the broader beauty incubator landscape.
The news that LVMH might sell off its stake in Rihanna’s Fenty raises questions about the broader beauty incubator landscape.
The French luxury giant has put aside its ambitions of running beauty in-house. Despite having an enviable stable of brands, the complexity of the business and mounting debt meant it wasn’t worth the pain.
The French luxury giant has put aside its ambitions of running beauty in-house. Despite having an enviable stable of brands, the complexity of the business and mounting debt meant it wasn’t worth the pain.
According to sources familiar with the company, the American giant is considering divesting assets as it struggles with weakened customer demand and unproven claims from the US president that Tylenol could be linked to autism.
According to sources familiar with the company, the American giant is considering divesting assets as it struggles with weakened customer demand and unproven claims from the US president that Tylenol could be linked to autism.
While the US beauty conglomerate unveils its first fragrance-focussed innovation centre in Paris, executives including CEO Stéphane de La Faverie outlined new opportunities for its luxury and prestige perfume portfolio, which spans brands like Tom Ford and Le Labo.
While the US beauty conglomerate unveils its first fragrance-focussed innovation centre in Paris, executives including CEO Stéphane de La Faverie outlined new opportunities for its luxury and prestige perfume portfolio, which spans brands like Tom Ford and Le Labo.
The pharmaceutical boom in weight-loss drugs has put companies like Novo Nordisk and Eli Lilly in ever-fiercer competition. Now more heavyweights, like Pfizer and Astrazeneca, are entering the ring. Who will come out on top?
The pharmaceutical boom in weight-loss drugs has put companies like Novo Nordisk and Eli Lilly in ever-fiercer competition. Now more heavyweights, like Pfizer and Astrazeneca, are entering the ring. Who will come out on top?
Industry coalition ReHubs is calling for billions of dollars of investment to establish industrialised textile recycling capabilities in Europe. For its strategy to work, many elements still need to fall into place.
Industry coalition ReHubs is calling for billions of dollars of investment to establish industrialised textile recycling capabilities in Europe. For its strategy to work, many elements still need to fall into place.
The industry is producing fewer emerging designer success stories, putting its pipeline of creative innovation at risk.
The industry is producing fewer emerging designer success stories, putting its pipeline of creative innovation at risk.
As consumer sentiment begins to dampen, the perfume industry’s explosive growth looks headed for a slowdown. Executives from Swiss fragrance and flavours firm Givaudan are confident in the strength of their business, but are diversifying into makeup, skincare and other categories to prepare.
As consumer sentiment begins to dampen, the perfume industry’s explosive growth looks headed for a slowdown. Executives from Swiss fragrance and flavours firm Givaudan are confident in the strength of their business, but are diversifying into makeup, skincare and other categories to prepare.
The company’s recovery plan is underway, and green shoots are appearing in key areas like China. But its core brands are still struggling, and competition is stacking up.
The company’s recovery plan is underway, and green shoots are appearing in key areas like China. But its core brands are still struggling, and competition is stacking up.
The executive order directs the FTC chairman to prioritise enforcement of existing laws against sellers and manufacturers who falsely claim products are made in America.
Owner Lanvin Group said it is ‘fully committed’ to the French label’s development under creative director Peter Copping, with CEO Andy Lew in charge of management.
Shares declined in after-hours trading as the beauty retailer expressed a cautious outlook for 2026.
The German water filtration firm has acquired a minority stake in Hello Klean, which sells shower heads it claims mitigate the effects of hard water.
The new tool published by the climate-focused nonprofit aims to create a standardised benchmark across textile facilities to accelerate fashion’s efforts to decarbonise.
The creative director’s departure after four years was a decision of ‘mutual agreement’ according to the Italian label.
The UK label will roll out its hero deodorant to Sephora US doors and launch its full assortment online as the LVMH-owned retailer expands its body care offering.
The European retailer forecast a rise in full-year adjusted operating profit and announced a share buyback, citing the productivity and cost-saving benefits of AI.